Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema in adults. The tablets are indicated to reduce blood phenylalanine levels in patients with ...
-- On track to report top-line Phase III results in mid-2006 -- Over 350 patients screened in 63 active sites worldwide -- 153 open-label attacks treated in Phase III trials BERLIN, March 6, 2006 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results